The beginning of enrollment is a significant milestone for the Company as we continue to evaluate the potential of this novel application in aortic therapies.” The study will enroll up to 15 patients outside of the United States.
The beginning of enrollment is a significant milestone for the Company as we continue to evaluate the potential of this novel application in aortic therapies.” The study will enroll up to 15 patients outside of the United States.